| Literature DB >> 27330732 |
Tatsuya Fukuda1, Ryotaro Bouchi1, Isao Minami1, Norihiko Ohara1, Yujiro Nakano1, Rie Nishitani1, Masanori Murakami1, Takato Takeuchi1, Momoko Akihisa1, Masamichi Fujita1, Hajime Izumiyama2, Koshi Hashimoto3, Takanobu Yoshimoto1, Yoshihiro Ogawa4.
Abstract
We present a case of a 62-year-old diabetic woman with acute pyelonephritis and spondylitis caused by Salmonella typhi. She was admitted to Tokyo Medical Dental University Hospital, Tokyo, Japan, because of unconsciousness and was diagnosed with sepsis by retrograde pyelonephritis as a result of Salmonella typhi. Antibiotics treatment was immediately started; however, she subsequently developed lumbar spondylitis, and long-term conservative treatment with antibiotics and a fixing device were required. This is the first report of a diabetic patient who developed retrograde urinary tract infection with Salmonella typhi, followed by sepsis and spondylitis. The infection could be a result of diabetic neuropathy, presenting neurogenic bladder and hydronephrosis. The patient was successfully treated with antibiotics and became asymptomatic with normal inflammatory marker levels, and no clinical sign of recurrence was observed in the kidney and spine at 4 months.Entities:
Keywords: Diabetic neuropathy; Retrograde pyelonephritis; Salmonella typhi
Mesh:
Year: 2015 PMID: 27330732 PMCID: PMC4847900 DOI: 10.1111/jdi.12375
Source DB: PubMed Journal: J Diabetes Investig ISSN: 2040-1116 Impact factor: 4.232
Laboratory data at admission
| Complete blood count | Urinalysis | Blood gas analysis | |||
|---|---|---|---|---|---|
| White blood cells | 21,600/μL | pH | 5.5 | pH | 7.494 |
| Red blood cells | 485 × 104/μL | Occult blood | (3+) | PaO2 | 75.1 |
| Hemoglobin | 14.1 g/dL | Glucose | (–) | PaCO2 | 38.6 |
| Hematocrit | 41.2% | Protein | (2+) | HCO3 − | 29.4 |
| Platelet | 17.2 × 104/μL | Ketone | (–) | Base excess | 6.2 |
| White blood cells | 50–99/HPF | ||||
| Blood chemistry | |||||
| Albumin | 2.2 mg/dL | AST | 45 IU/L | Glucose | 845 mg/dL |
| BUN | 75 mg/dL | ALT | 39 IU/L | HbA1c | 11.5% |
| Creatinine | 1.25 mg/dL | Total bilirubin | 0.7 mg/dL | C‐reactive protein | 22.53 mg/dL |
| Na | 140 mEq/L | γ‐GTP | 57 IU/L | ||
| K | 3.7 mEq/L | CK | 52 IU/L | ||
| Cl | 97 mEq/L | Amylase | 56 IU/L | ||
γ‐GTP, gamma‐glutamyl transpeptidase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BUN, blood urea nitrogen; CK, creatine kinase; HbA1c, glycated hemoglobin.
Figure 1Abdominal computed tomography on admission.
Figure 2Clinical course.
Figure 3Lumbar magnetic resonance imaging at 1 month after admission.